يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"follow-up (FU)"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Fritzsching, B., Contoli, M., Porsbjerg, C., Buchs, S., Larsen, J. R., Elliott, L., Rodriguez, M. R., Freemantle, N.

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34901915; info:eu-repo/semantics/altIdentifier/wos/WOS:000765033800011; volume:13; firstpage:100275-1; lastpage:100275-12; numberofpages:12; journal:THE LANCET REGIONAL HEALTH. EUROPE; https://hdl.handle.net/11392/2474403Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120177384; https://www.sciencedirect.com/science/article/pii/S2666776221002611Test

  3. 3

    المصدر: The Lancet Regional Health-Europe
    Fritzsching, B, Contoli, M, Porsbjerg, C, Buchs, S, Larsen, J R, Elliott, L, Rodriguez, M R & Freemantle, N 2022, ' Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma : Results from the REACT study, a retrospective cohort study. ', The Lancet Regional Health-Europe, vol. 13, 100275 . https://doi.org/10.1016/j.lanepe.2021.100275Test
    The Lancet Regional Health. Europe, Vol 13, Iss, Pp 100275-(2022)

    مصطلحات موضوعية: Allergy, INCS, intranasal corticosteroids, Effectiveness, short-acting beta2-agonists (SABA), sublingual immunotherapy (SLIT), Allergic rhinitis, HDM, house dust mite, law.invention, AR, allergic rhinitis, intranasal corticosteroids (INCS), Randomized controlled trial, law, house dust mite (HDM), FU, follow-up, inhaled corticosteroids (ICS), SCIT, subcutaneous immunotherapy, retrospective cohort study, Real-world evidence, RCT, randomised clinical trial, biology, Health Policy, subcutaneous immunotherapy (SCIT), Oncology, HRU, health care resource utilisation, Cohort, Public aspects of medicine, RA1-1270, LABA, long-acting beta2-agonists, propensity score matching (PSM), real world evidence (RWE), Research Paper, Allergy immunotherapy (AIT), Retrospective cohort study, PSM, propensity score matching, medicine.medical_specialty, Allergen immunotherapy, allergic rhinitis (AR), Socio-culturale, effectiveness, health care resource utilisation (HRU), AIT, allergy immunotherapy, Rx prescription, Internal medicine, Internal Medicine, medicine, SABA, short-acting beta2-agonists, RWE, real world evidence, Asthma, House dust mite, business.industry, Rx, prescription, asthma, SLIT, sublingual immunotherapy, allergy, medicine.disease, biology.organism_classification, ICS, inhaled corticosteroids, randomised clinical trial (RCT), Allergy immunotherapy, follow-up (FU), Propensity score matching, Allergy immunotherapy (AIT), allergic rhinitis (AR), allergy, asthma, effectiveness, follow-up (FU), house dust mite (HDM), health care resource utilisation (HRU), inhaled corticosteroids (ICS), intranasal corticosteroids (INCS), long-acting beta2-agonists (LABA), propensity score matching (PSM), randomised clinical trial (RCT), real world evidence (RWE), retrospective cohort study, Rx prescription, short-acting beta2-agonists (SABA), subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT), long-acting beta2-agonists (LABA), business

    وصف الملف: application/pdf